Advertisement

Topics

M&As this week: Advent International, Eli Lilly

19:00 EDT 28 Jun 2018 | Pharmaceutical Technology

Advent International has entered an agreement to purchase Sanofi’s European generics business Zentiva for €1.9bn ($2.2bn). Advent intends to invest...
Read More...

The post M&As this week: Advent International, Eli Lilly appeared first on Pharmaceutical Technology.

Original Article: M&As this week: Advent International, Eli Lilly

NEXT ARTICLE

More From BioPortfolio on "M&As this week: Advent International, Eli Lilly"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...